Can you transmit Herpes Simplex Virus (HSV) 2 without visible lesions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HSV-2 Can Be Transmitted Without Visible Lesions

Yes, HSV-2 can definitely be transmitted in the absence of visible lesions through asymptomatic viral shedding. 1 This is one of the primary reasons why genital herpes continues to spread widely despite awareness of the disease.

Transmission Mechanisms

HSV-2 transmission without visible lesions occurs through:

  1. Asymptomatic viral shedding:

    • HSV-2 can be shed from genital surfaces even when no symptoms are present
    • Many cases of genital herpes are transmitted during these asymptomatic periods 1
    • The virus can be present on mucosal or skin surfaces without causing noticeable symptoms
  2. Subclinical infections:

    • 80-90% of genital herpes infections progress subclinically 1
    • Infected individuals may be unaware they carry the virus
    • These asymptomatic carriers represent a significant reservoir for transmission

Risk Reduction Strategies

To reduce transmission risk when no lesions are present:

  • Consistent condom use: Latex condoms reduce HSV-2 acquisition from women to men and from men to women 1

  • Suppressive antiviral therapy:

    • Daily suppressive therapy (valacyclovir 500mg once daily) reduced HSV-2 transmission to susceptible heterosexual partners by 50% 1
    • For those with frequent recurrences, suppressive therapy with valacyclovir 500mg twice daily is recommended for HIV-infected persons 1, 2
  • Partner testing: HSV-2-seronegative individuals should ask partners to be tested using type-specific serology before initiating sexual activity 1

  • Disclosure: Informing partners about HSV-2 status has been associated with reduced transmission risk 1

Important Clinical Considerations

  1. Asymptomatic shedding patterns:

    • HSV-2 can spread locally within genital epithelium extremely rapidly (within hours) 3
    • Even without visible lesions, thousands of epithelial cells can be infected in <12 hours 3
  2. Testing limitations:

    • Clinical diagnosis without laboratory confirmation is unreliable, especially in HIV-positive patients 1
    • PCR is the most sensitive method for detecting HSV in genital specimens 1
    • Type-specific serologic assays can identify asymptomatic carriers 1
  3. Special populations:

    • HIV-infected individuals have higher rates of HSV-2 seropositivity (approximately 70%) 1
    • Immunocompromised patients may have more frequent asymptomatic shedding 2
    • Pregnant women should be counseled about the risk of transmission during pregnancy and delivery 1

Common Pitfalls in Managing Transmission Risk

  1. Assuming no risk without lesions: Many healthcare providers and patients incorrectly believe transmission only occurs during symptomatic episodes

  2. Inadequate counseling: Patients should be explicitly informed that genital herpes is frequently transmitted in the absence of symptoms through asymptomatic viral shedding 1, 4

  3. Relying solely on episodic treatment: While episodic treatment helps with symptoms, it does not reduce asymptomatic shedding or transmission risk as effectively as suppressive therapy 1

  4. Ignoring type-specific testing: Type-specific serologic testing should be considered for accurate diagnosis, as HSV-1 recurs less frequently than HSV-2 in the genital area 1

The evidence clearly demonstrates that HSV-2 transmission commonly occurs during periods without visible lesions, highlighting the importance of preventive measures beyond simply avoiding contact during symptomatic outbreaks.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Uncomplicated Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.